New Delhi, May 19 (IANS) The Central Drugs Standard Control Organisation (CDSCO) said that cosmetic products are not permitted to be used through injections and warned that such practices violate provisions of the Drugs and Cosmetics Act, 1940, and Cosmetics Rules, 2020, according to a notice released on Tuesday.In a public notice, the CDSCO said products supplied in injectable form do not fall under the definition of cosmetics and cannot be used by consumers, professionals or aesthetic clinics….
Latest CDSCO News & Updates
New Delhi, April 22 (IANS) Approximately 10 per cent of districts in the country currently do not have a blood centre, underscoring the need for accelerated expansion of infrastructure, an official statement said on Wednesday.Similarly, gaps remain in digital integration, with a significant number of blood centres yet to be onboarded on eRaktKosh and BBMS, limiting real-time visibility and monitoring, according to the outcomes of a national-level meeting convened by Health Ministry on India’s …
New Delhi, March 19 (IANS) Regulatory bodies have issued national guidelines to ensure safe, ethical deployment of CRISPR-based therapies in India, while the BioE3 is accelerating indigenous capacity for cell and gene therapeutics, the government said on Thursday responding to a question on self-reliance in CRISPR and gene editing.The government through various programs has been steadily advancing the precision medicine ecosystem with a strong emphasis on next-generation cell and gene therapies …
New Delhi, March 4 (IANS) India’s global chemical sector share is set to increase to 5-6 per cent by 2030 and achieve a $1 trillion turnover by 2040, according to the government.According to Union Minister JP Nadda, the budgetary provision of Rs 13,000 crore for Bio-Pharma SHAKTI and three dedicated Chemical Parks in the country is a strategic bet on India’s future.Addressing a post-Budget webinar, the minister said that 40 per cent of medicines globally will be biologics by 2035. About $300…
New Delhi, Feb 21 (IANS) India’s pharmaceutical exports grew by 9.4 per cent in 2024–25 to reach $30.47 billion, and the industry is now preparing to achieve double-digit growth in 2026–27 with strong government support, the Ministry of Commerce and Industry said on Saturday.The interaction, organised on the theme “Scaling up Pharma Exports,” reflected the government’s focus on expanding India’s global footprint in medicines through closer coordination with industry and regulators….
New Delhi, Feb 10 (IANS) AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation (CDSCO) to sell and distribute Durvalumab solution for infusion used in cancer treatment for an additional indication.In its latest stock exchange filing, the drug company said that through this approval, “Durvalumab in combination with carboplatin and paclitaxel is indicated for the first-line treatment of adults with primary advanced or rec…
New Delhi, Feb 1 (IANS) Union Health Minister J.P. Nadda stated that the 176 per cent increase in the health sector budget over the past 12 years reflects the Modi government’s commitment to making healthcare accessible to all.Welcoming the Union Budget 2026, the Union Minister mentioned that the funds allocated to the health sector this year are approximately 9 per cent more than last year.In a video message, Nadda said, “The Union Budget 2026-27, presented by Union Finance Minister Nirmala Sit…
New Delhi, Jan 28 (IANS) Union Ministry of Health and Family Welfare on Tuesday notified key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, which will help reduce drug development timelines, as well as strengthen the clinical research and pharmaceutical development ecosystem.The amendments are aimed at simplifying regulatory processes, reducing approval timelines, and promoting ease of doing business.The regulatory reforms will provide substantial benefits to stakeholders wh…
New Delhi, Jan 21 (IANS) The Central Drugs Standard Control Organisation (CDSCO) on Wednesday declared 167 drug samples tested by the Central and state drugs regulatory authorities as ‘not of standard quality (NSQ)’ in its monthly drug alert for December.While the Central Drugs Laboratories identified 74 drug samples as NSQ, the State Drugs Testing Laboratories identified 93 drug samples as NSQ.As per routine regulatory surveillance activity, the list of NSQ and spurious drugs is being display…